Semaglutide - Tirzepatide
NEW Patient Special available!
The program includes healthy recipe ideas, general health/wellness tips, Weight loss education and WEEKLY SHOT!!

Semaglutide / Tirzepatide

At MindBodySoul Mental Health & Family Practice Services in Decatur, GA, we offer Semaglutide and Tirzepatide injections, which not only aid in achieving weight loss but also contribute to maintaining it. These injections effectively curb appetite, often accompanied by recommended dietary and exercise modifications for enhanced results.

Semaglutide - Tirzepatide

HOW OUR SEMAGLUTIDE / TIRZEPATIDE PROTOCOL WORKS

Schedule a zoom consultation with one of our Nurse Practitioners. At the consultation, we will review your pre-filled medical questionnaire, and provide extensive education the medication, self injection technique, and diet. 

After your consultation, we ship the medication and injection supplies directly to your home from the pharmacy to cover 10/16 weeks of injection supplies following the standard graduated dosing per protocol. 

Lose weight, and check in with us periodically to monitor your progress. After your initial protocol, we can continue you on further shipments of medication tailored to your personalized dosing and weight loss goals.

WHO ARE THE BEST CANDIDATES FOR SEMAGLUTIDE & TIRZEPATIDE?

FDA_approverd
we believe the best candidates for Semaglutide and Tirzepatide in Laurel, Maryland are:
Suitable candidates for treatment are adults with a BMI of 30 kg/m² or higher, or 27 kg/m² with at least one weight-related condition such as high blood pressure, high cholesterol, or Type 2 Diabetes. They should possess realistic expectations for their outcomes, maintain a positive mindset throughout the treatment process, and demonstrate a commitment to sustaining a healthy lifestyle.
Semaglutide stands as a powerful tool in the fight against excess weight, but it’s essential to determine if it aligns with your specific needs. FDA-approved for medical weight loss since 2021, this injection is suitable for adults seeking effective weight management and loss. Ideal candidates possess a BMI exceeding 30 or a BMI of 27 or higher while contending with weight-related medical conditions like type 2 diabetes, high cholesterol, or high blood pressure.

Advantages of Semaglutide/ Tirzepatide Therapies:

  1. Sustained relief for ongoing weight control
  2. Effective weight management remedy
  3. Streamlines the weight loss process
  4. Curbs those nagging hunger pangs
  5. Prolongs the sensation of fullness
  6. Diminishes those troublesome cravings
  7. Potential to enhance blood sugar regulation
  8. Amps up the body’s fat-burning capacity
  9. Maintains your emotional equilibrium
  10. Endorsed by the FDA as an injectable prescription

WHAT IS SEMAGLUTIDE FOR WEIGHT LOSS?

Originally developed to manage type 2 diabetes, Semaglutide has emerged as a promising player in the realm of weight management. When harnessed for weight loss purposes, Semaglutide is administered at a higher dosage compared to its diabetes treatment counterpart. This once-weekly injection activates GLP-1 receptors in the brain, effectively curbing cravings and enhancing the sensation of fullness. By moderating food intake and catalyzing weight loss, Semaglutide emerges as a valuable ally for those grappling with obesity or excess weight.
In clinical trials, Semaglutide has proven its prowess in promoting substantial weight loss. Notably, a study featured in the New England Journal of Medicine in 2021 showcased remarkable results: individuals receiving Semaglutide for 68 weeks experienced an average weight reduction of 15.3% of their body weight, in stark contrast to the mere 2.4% observed in the placebo group.

WHAT IS TIRZEPATIDE FOR WEIGHT LOSS?

While initially developed by Eli Lilly and Company for managing type 2 diabetes, Tirzepatide is now capturing attention as a potential solution for weight management.
Much like Semaglutide, Tirzepatide operates by activating GLP-1 receptors in the brain, effectively curbing appetite and enhancing the feeling of fullness. However, what sets Tirzepatide apart is its dual action—it also activates GIP receptors, prompting insulin secretion from the pancreas in response to food consumption. By targeting both GIP and GLP-1 receptors, Tirzepatide demonstrates superior efficacy in lowering blood sugar levels and fostering weight loss when compared to GLP-1 receptor agonists alone.
In clinical trials, Tirzepatide has showcased encouraging outcomes in promoting weight loss. A noteworthy phase II clinical trial, featured in The Lancet in 2021, revealed that individuals receiving Tirzepatide for 26 weeks achieved an average weight reduction of 11.3% of their body weight, a remarkable contrast to the 2.4% observed in the placebo group.

WHAT’S THE DIFFERENCE BETWEEN SEMAGLUTIDE AND TIRZEPATIDE

While Semaglutide and Tirzepatide are both injectable medications employed in the treatment of type 2 diabetes, they operate with subtle distinctions.
 
Semaglutide functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, mirroring the effects of GLP-1, a gut-produced hormone that triggers insulin secretion, curbs glucagon release, and decelerates gastric emptying. By activating GLP-1 receptors, Semaglutide facilitates blood sugar reduction and fosters weight loss.
 
On the other hand, Tirzepatide serves as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. While it shares the GLP-1 receptor activation mechanism with Semaglutide, it goes a step further by also stimulating GIP receptors. This dual action encourages insulin secretion from the pancreas in response to food intake. By targeting both GIP and GLP-1 receptors, Tirzepatide boasts superior efficacy in lowering blood sugar levels and promoting weight loss when compared to GLP-1 receptor agonists alone.
 
In terms of dosing, Semaglutide is available in a once-weekly injectable form, while Tirzepatide is also administered once weekly. However, Tirzepatide comes in higher doses than Semaglutide, and clinical trials have demonstrated its heightened effectiveness in reducing blood sugar levels and facilitating weight loss.
 
In conclusion, both Semaglutide and Tirzepatide stand as effective treatments for type 2 diabetes. Yet, they diverge in their mechanisms and dosing requirements. The choice between these medications may be influenced by individual patient needs and preferences, as well as the specific goals of treatment.

Begin Your Weight Loss Journey with Semaglutide Injections

NEW Patient Special available!
The program includes healthy recipe ideas, general health/wellness tips, Weight loss education and WEEKLY SHOT!!

Frequently Asked Question

What Weight Loss Can You Achieve? Numerous trials and research studies confirm the effectiveness of Semaglutide in combating obesity. Participants administered Semaglutide at 2.4 mg experienced an average weight reduction of 6% by the 12th week and an impressive 12% by the 28th week. It’s important to note that individual outcomes may differ.

Semaglutide is meticulously crafted with your well-being at its core! This exceptional weight loss remedy is formulated to empower your body to shed those extra pounds in a groundbreaking manner—by revving up your metabolism, amplifying fat-burning prowess, and curbing those persistent hunger cravings. It’s worth noting that individual weight loss achievements may naturally differ

Most patients begin seeing a decline in their blood sugar levels within the first week of treatment. However, full effects take 8 weeks or longer. It is important to remember that Semaglutide is a long-acting medication you receive as an injectable once per week for the duration of treatment. As always, results and experiences will vary per person.

Semaglutide is offered as a weight loss prescription. It requires authorization from a medical provider. If you have questions about the new prescription medication and want to learn more about the benefits it could have on your body, contact your primary care doctor or a Semaglutide provider.

Semaglutide is offered as a weight loss prescription. It requires authorization from a medical provider. If you have questions about the new prescription medication and want to learn more about the benefits it could have on your body, contact your primary care doctor or a Semaglutide provider.

Tirzepatide is an FDA approved injectable glucagon-like peptide-1 (GLP-1) agonist that is administered once weekly to aid in weight loss. In a clinical trial, participants taking Tirzepatide lost 15% of their body weight, on average. 

Tirzepatide is a GLP-1 and GIP agonist, mimicking the action of incretin hormones that play a role in your appetite and digestion. Incretins are hormones released by your small intestine and are sent out to your body after you have eaten a meal. The incretins trigger insulin production and block other sources of sugar. This is how your body stabilizes your blood sugar.   Tirzepatide also slows gastric emptying , which is how quickly food leaves your stomach after eating.  This causes you to feel full longer, which decreases your appetite and aids in losing weight. Lastly, Tirzepatide works at the hunger center of your brain to dampen your appetite. Tirzepatide promotes weight loss by empowering you to eat less calories on a daily basis.

You’ll take charge of the Semaglutide or Tirzepatide injections using a minuscule syringe and needle, similar in size to those used for insulin injections. During your consultation, we’ll provide comprehensive training on the proper method for drawing up and administering Semaglutide or Tirzepatide. These injections are administered into the subcutaneous tissue surrounding your stomach area. You’ll experience only a minor pinprick sensation as the small needle enters, making it a relatively painless process. If self-injection isn’t your preference, an adult family member can assist you with the Semaglutide or Tirzepatide injections

The most common side effects are GI related. Constipation and some underlying queasiness are common when you first start the medication, and each time you go up in dosing. Rarely, pt’s will report severe nausea the week after starting Semaglutide or Tirzepatide. If this happens, we call in Zofran to your preferred pharmacy.

Scroll to Top